[EN] INHIBITORS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES 1 AND 4 [FR] INHIBITEURS DE KINASES 1 ET 4 ASSOCIÉES AU RÉCEPTEUR DE L'INTERLEUKINE 1
摘要:
The present disclosure provides compounds that are inhibitors of interleukin-1 receptor-associated kinases 1 and 4 (IRAK1 and IRAK4) and their use in the treatment of medical disorders such as autoimmune disorders, cancer, and pain disorders.